216 related articles for article (PubMed ID: 17367259)
1. Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin.
Sommer BR; Fenn HH; Ketter TA
Expert Opin Drug Saf; 2007 Mar; 6(2):133-45. PubMed ID: 17367259
[TBL] [Abstract][Full Text] [Related]
2. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
Rosa AR; Fountoulakis K; Siamouli M; Gonda X; Vieta E
CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
[TBL] [Abstract][Full Text] [Related]
4. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.
Lai EC; Hsieh CY; Su CC; Yang YK; Huang CW; Lin SJ; Setoguchi S
Medicine (Baltimore); 2016 Aug; 95(35):e4481. PubMed ID: 27583857
[TBL] [Abstract][Full Text] [Related]
5. New antiepileptic drugs in pediatric epilepsy.
Hwang H; Kim KJ
Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
[TBL] [Abstract][Full Text] [Related]
6. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
Pinheiro D
Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of new antiepileptic drugs.
Gram L
Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant drug therapies.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2005 Jun; 43(6):17-20. PubMed ID: 16018130
[No Abstract] [Full Text] [Related]
10. Effects of antiepileptic drugs on cognition.
Aldenkamp AP
Epilepsia; 2001; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358
[No Abstract] [Full Text] [Related]
11. Epilepsy in children: the evidence for new antiepileptic drugs.
Verdru P
Acta Neurol Scand Suppl; 2005; 181():17-20. PubMed ID: 16238703
[TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drugs in the treatment of neuropathic pain.
Eisenberg E; River Y; Shifrin A; Krivoy N
Drugs; 2007; 67(9):1265-89. PubMed ID: 17547471
[TBL] [Abstract][Full Text] [Related]
13. Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study.
Falhammar H; Lindh JD; Calissendorff J; Farmand S; Skov J; Nathanson D; Mannheimer B
Seizure; 2018 Jul; 59():28-33. PubMed ID: 29730273
[TBL] [Abstract][Full Text] [Related]
14. [Neuromuscular disorders caused by adverse effects of antiepileptics].
Takahashi Y
Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1608-13. PubMed ID: 17802709
[No Abstract] [Full Text] [Related]
15. [Empirical evidence for the use of anticonvulsants in personality disorders].
Sieberer M; Emrich HM
Fortschr Neurol Psychiatr; 2009 Mar; 77(3):133-8. PubMed ID: 19283647
[TBL] [Abstract][Full Text] [Related]
16. Emergent complications of the newer anticonvulsants.
Wade JF; Dang CV; Nelson L; Wasserberger J
J Emerg Med; 2010 Feb; 38(2):231-7. PubMed ID: 18762404
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
[TBL] [Abstract][Full Text] [Related]
18. Important pharmacokinetic properties of antiepileptic drugs.
Bourgeois BF
Epilepsia; 1995; 36 Suppl 5():S1-7. PubMed ID: 8806398
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs.
Perucca E
Epilepsia; 1996; 37 Suppl 2():S8-S13. PubMed ID: 8641245
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model--an isobolographic analysis.
Luszczki JJ; Andres MM; Czuczwar SJ
Eur J Pharmacol; 2005 May; 515(1-3):54-61. PubMed ID: 15894310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
